Tamar Thompson is Director of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 3,773 shares of CPRX, which is worth approximately $87,458. The most recent transaction as insider was on Dec 08, 2025, when has been sold 1,413 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.77K
167.02% 3M change
167.02% 12M change
Total Value Held $87,458

Tamar Thompson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 08 2025
BUY
Exercise of conversion of derivative security
-
1,413 Added 27.25%
3,773 Common Stock, par valu...
Nov 21 2025
BUY
Exercise of conversion of derivative security
-
947 Added 28.64%
2,360 Common Stock, par valu...
Dec 09 2024
BUY
Exercise of conversion of derivative security
-
1,413 Added 50.0%
1,413 Common Stock, par valu...

Also insider at

RNA
Avidity Biosciences, Inc. Healthcare
TT

Tamar Thompson

Director
San Diego, CA

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX